120 Mg Denosumab Injection IP

Name: 120 Mg Denosumab Injection IP
Brand: NEETCO BIOPHARMA
Price: 21999 INR
Availability: InStock

Price 21999 INR/ Vial

Get a Price/Quote

MOQ : 1 Vial

120 Mg Denosumab Injection IP Specification

Salt Composition
Denosumab 120 mg

Dosage Form
Injection

Indication
Osteoporosis, treatment of bone loss, prevention of skeletal-related events in patients with bone metastases from solid tumors

Feature
Single use, pre-filled syringe

Ingredients
Denosumab, excipients, water for injection

Application
Subcutaneous administration

Ph Level
6.0 6.5

Physical Color/Texture
Clear, colorless to pale yellow solution

Fermentation Smell
Odorless

Storage Instructions
Store in a refrigerator at 2C to 8C. Do not freeze.

Shelf Life
24 months

About 120 Mg Denosumab Injection IP

Access the potent and spectacular efficacy of 120 Mg Denosumab Injection IP, offered in a single-use, pre-filled syringe containing 120 mg/1.7 ml solution. This prescription-only medication has garnered favorable reviews for its majestic ability to treat osteoporosis, prevent bone loss, and reduce skeletal-related events in patients with bone metastases. For a limited time, benefit from premium distribution across India by reliable exporters and traders. The clear, odorless solution is administered subcutaneously and requires careful calcium monitoring. Secure, swift delivery ensures optimum patient care.

Premium Applications & Features of 120 Mg Denosumab Injection IP

The 120 Mg Denosumab Injection IP is used for osteoporosis, bone loss treatment, and prevention of skeletal complications in cancer patients. Its primary competitive advantage lies in high bioavailability, single-use pre-filled syringe material, and favorable safety profile. Tried and trusted, it boasts robust performance, contributing to exceptional patient outcomes. With easy subcutaneous administration, it enhances both clinic efficiency and patient compliance.

120 Mg Denosumab Injection IP - Packaging & Market Reach

Each Denosumab injection is smartly packaged in a pre-filled syringe, ensuring quick dispatch and delivery for exporters, distributors, and traders. With a shelf life of 24 months, the packaging safeguards product quality until use. The main export markets include Asia, Africa, and the Middle East, while the domestic market spans major Indian cities. Prompt delivery and reliable storage conditions guarantee customer satisfaction and product integrity.

FAQ's of 120 Mg Denosumab Injection IP:

Q: How should the 120 Mg Denosumab Injection IP be stored prior to use?

A: The injection must be stored in a refrigerator between 2C and 8C and should not be frozen. After opening, it should be used immediately to maintain efficacy and safety.

Q: What are the primary indications for using Denosumab Injection IP?

A: Denosumab Injection IP is indicated for treating osteoporosis, bone loss, and for preventing skeletal-related events in patients with bone metastases from solid tumors.

Q: When should patients avoid using Denosumab Injection IP?

A: Patients with hypersensitivity to Denosumab or with existing hypocalcemia should not use this medication. Regular calcium level monitoring is essential during its administration.

Q: Where is 120 Mg Denosumab Injection IP primarily distributed and exported?

A: The product is distributed throughout India and exported to markets in Asia, Africa, and the Middle East, ensuring broad availability and quick access.

Q: What is the process for inspecting the Denosumab Injection before administration?

A: Visually inspect the solution before use; do not administer if it appears cloudy or contains particulate matter. Only a clear, colorless to pale yellow solution should be used for injection.

Q: How does the usage of Denosumab Injection IP benefit patients?

A: Patients benefit from improved bone density, reduced fracture risk, and decreased skeletal events associated with cancers, contributing to better long-term health outcomes.

Tell us about your requirement